Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 Nov 23 424B3 Prospectus supplement
- 13 Nov 23 F-4/A Registration of securities (foreign) (amended)
- 13 Nov 23 F-4/A Registration of securities (foreign) (amended)
- 13 Nov 23 EFFECT Notice of effectiveness
-
3 Nov 23 F-4/A Registration of securities (foreign) (amended)
- 16 Oct 23 F-4/A Registration of securities (foreign) (amended)
- 20 Sep 23 F-4/A Registration of securities (foreign) (amended)
- 31 Jul 23 F-4 Registration of securities (foreign)
PBM similar filings
Filing view
External links
Exhibit 99.4
CONSENT TO BE NAMED AS A DIRECTOR
November 2, 2023
In connection with the filing by Psyence Biomedical Ltd. of the Registration Statement on Form F-4 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of Psyence Biomedical Ltd. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
Sincerely, | |
/s/ Seth Feuerstein | |
Seth Feuerstein |